Share Email Print
cover

Proceedings Paper

Microlocalization of Photofrin in neoplastic lesions
Author(s): Mladen Korbelik; Gorazd Krosl; Stephen Lam; David J. Chaplin; Branko Palcic
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Three tumor models were used to study the microlocalization of two photosensitizers, Photofrin and TPPS4 (mesotetra[p-sulphophenyl]porphyne). The three tumor types employed were subcutaneously and intramuscularly grown murine Lewis lung carcinoma, and lung micrometastases, grown on the same animal. The objective of the study was to determine whether these photosensitizers localize differently in these three tumor types. Common to all the tumors was the observation that no substantial photosensitizer fluorescence could be found in the tumor parenchyma. With Photofrin, most of the drug fluorescence was found in the periphery of the tumors, especially around blood vessels and possibly in some macrophages. On the other hand with TPPS4, most of the fluorescence was seen in the basement membrane of blood vessels and airways. The photosensitizer TPPS4 may therefore accumulate less specifically in tumor microenvironment than Photofrin. Both photosensitizers were also found to localize in necrotic areas.

Paper Details

Date Published: 1 June 1991
PDF: 8 pages
Proc. SPIE 1426, Optical Methods for Tumor Treatment and Early Diagnosis: Mechanisms and Techniques, (1 June 1991); doi: 10.1117/12.44056
Show Author Affiliations
Mladen Korbelik, British Columbia Cancer Research Ctr. (Canada)
Gorazd Krosl, British Columbia Cancer Research Ctr. (Canada)
Stephen Lam, British Columbia Cancer Research Ctr. (Canada)
David J. Chaplin, British Columbia Cancer Research Ctr. (Canada)
Branko Palcic, British Columbia Cancer Research Ctr. (Canada)


Published in SPIE Proceedings Vol. 1426:
Optical Methods for Tumor Treatment and Early Diagnosis: Mechanisms and Techniques
Thomas J. Dougherty, Editor(s)

© SPIE. Terms of Use
Back to Top